Skip to main content
Erschienen in: Surgical Endoscopy 4/2010

01.04.2010

Ramosetron versus ondansetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy

verfasst von: Junghee Ryu, Yun-Mi So, Jungwon Hwang, Sang-Hwan Do

Erschienen in: Surgical Endoscopy | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients undergoing general anesthesia for laparoscopic cholecystectomy are at high risk for postoperative nausea and vomiting (PONV). This study compared ramosetron and ondansetron in terms of efficacy for PONV prevention after laparoscopic cholecystectomy.

Methods

For this study, 120 patients scheduled to undergo laparoscopic cholecystectomy were randomized (in double-blind fashion) to receive 4 mg of ondansetron (group O4, n = 40), 8 mg of ondansetron (group O8, n = 40), or 0.3 mg of ramosetron (group R, n = 40) intravenously after surgery. Postoperative nausea, retching, vomiting, pain, and side effects were assessed at 2 h, 24 h, and 48 h after surgery.

Results

No statistical differences were observed among the three groups with regard to patient characteristics and information on surgery and anesthesia. The ratio of complete response (no PONV for 2 h) was higher for groups O8 and R than for group O4 as follows: 80% (n = 32) for groups O8 and R versus 58% (n = 23) for group O4 during the first postoperative 2 h (p = 0.04), 90% (n = 36) for groups O8 and R versus 76% (n = 30) for group O4 over 24 h (2–24 h) (p = 0.09), and 98% (n = 38) for groups O4 and O8 versus 100% (n = 40) for group R over the next 24 h (24–48 h) after surgery (p = 0.36). During the first 2 h after surgery, rescue antiemetics were used for significantly fewer patients in groups O8 and R (20%) than in group O4 (42.5%) (p = 0.04). Postoperative pain and the use of rescue analgesics were comparable among the groups. There was no clinically serious adverse event due to the study drugs.

Conclusion

Ramosetron 0.3 mg and ondansetron 8 mg are more effective than ondansetron 4 mg for the prevention of PONV (2 h). Ramosetron 0.3 mg is as effective as ondansetron 8 mg for the prophylaxis of PONV after laparoscopic cholecystectomy.
Literatur
1.
Zurück zum Zitat Watcha MF, White PF (1992) Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 77:161–184CrossRef Watcha MF, White PF (1992) Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 77:161–184CrossRef
2.
Zurück zum Zitat Gan TJ, Meyer T, Apfel CC, Chung F, Davis PJ, Eubanks S, Kovac A, Philip BK, Sessler DI, Temo J, Tramèr MR, Watcha M (2003) Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 97:62–71CrossRefPubMed Gan TJ, Meyer T, Apfel CC, Chung F, Davis PJ, Eubanks S, Kovac A, Philip BK, Sessler DI, Temo J, Tramèr MR, Watcha M (2003) Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 97:62–71CrossRefPubMed
3.
Zurück zum Zitat Stadler M, Bardiau F, Seidel L, Albert A, Boogaerts JG (2003) Difference in risk factors for postoperative nausea and vomiting. Anesthesiology 98:46–52CrossRefPubMed Stadler M, Bardiau F, Seidel L, Albert A, Boogaerts JG (2003) Difference in risk factors for postoperative nausea and vomiting. Anesthesiology 98:46–52CrossRefPubMed
4.
Zurück zum Zitat Tramer MR (2004) Strategies for postoperative nausea and vomiting. Best Pract Res Clin Anaesthesiol 18:693–701CrossRefPubMed Tramer MR (2004) Strategies for postoperative nausea and vomiting. Best Pract Res Clin Anaesthesiol 18:693–701CrossRefPubMed
5.
Zurück zum Zitat Fujii Y (2005) The utility of antiemetics in the prevention and treatment of postoperative nausea and vomiting in patients scheduled for laparoscopic cholecystectomy. Curr Pharmaceut Des 11:3173–3183CrossRef Fujii Y (2005) The utility of antiemetics in the prevention and treatment of postoperative nausea and vomiting in patients scheduled for laparoscopic cholecystectomy. Curr Pharmaceut Des 11:3173–3183CrossRef
6.
Zurück zum Zitat Nesek-Adam V, Grizelj-Stojcic E, Rasic Z, Cala Z, Mrsic V, Smiljanic A (2007) Comparison of dexamethasone, metoclopramide, and their combination in the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Surg Endosc 21:607–612CrossRefPubMed Nesek-Adam V, Grizelj-Stojcic E, Rasic Z, Cala Z, Mrsic V, Smiljanic A (2007) Comparison of dexamethasone, metoclopramide, and their combination in the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Surg Endosc 21:607–612CrossRefPubMed
7.
Zurück zum Zitat Santon JM (1991) Anaesthesia for laparoscopic cholecystectomy. Anaesthesia 46:317CrossRef Santon JM (1991) Anaesthesia for laparoscopic cholecystectomy. Anaesthesia 46:317CrossRef
8.
Zurück zum Zitat Thune A, Appelgren L, Haglind E (1995) Prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a prospective randomized study of metoclopramide and transdermal hyoscine. Eur J Surg 161:265–268PubMed Thune A, Appelgren L, Haglind E (1995) Prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a prospective randomized study of metoclopramide and transdermal hyoscine. Eur J Surg 161:265–268PubMed
9.
Zurück zum Zitat Sohi HS, Heipel J, Inman KJ, Chinnick B, Cunningham DG, Holliday RL, Girotti MJ (1994) Preoperative transdermal scopolamine does not reduce the level of nausea and frequency of vomiting after laparoscopic cholecystectomy. Can J Surg 37:307–312PubMed Sohi HS, Heipel J, Inman KJ, Chinnick B, Cunningham DG, Holliday RL, Girotti MJ (1994) Preoperative transdermal scopolamine does not reduce the level of nausea and frequency of vomiting after laparoscopic cholecystectomy. Can J Surg 37:307–312PubMed
10.
Zurück zum Zitat Kothari SN, Boyd WC, Bottcher ML, Lambert PJ (2000) Antiemetic efficacy of prophylactic dimenhydrinate (Dramamine) vs ondansetron (Zofran): a randomized, prospective trial of inpatients undergoing laparoscopic cholecystectomy. Surg Endosc 14:926–929CrossRefPubMed Kothari SN, Boyd WC, Bottcher ML, Lambert PJ (2000) Antiemetic efficacy of prophylactic dimenhydrinate (Dramamine) vs ondansetron (Zofran): a randomized, prospective trial of inpatients undergoing laparoscopic cholecystectomy. Surg Endosc 14:926–929CrossRefPubMed
11.
Zurück zum Zitat Parlow JL, Meikle AT, van Vlymen J, Avery N (1999) Postdischarge nausea and vomiting after ambulatory laparoscopy is not reduced by promethazine prophylaxis. Can J Anaesth 46:719–724CrossRefPubMed Parlow JL, Meikle AT, van Vlymen J, Avery N (1999) Postdischarge nausea and vomiting after ambulatory laparoscopy is not reduced by promethazine prophylaxis. Can J Anaesth 46:719–724CrossRefPubMed
12.
Zurück zum Zitat Fujii Y, Tanaka H, Toyooka H (1999) Prophylactic antiemetic therapy with droperidol in patients undergoing laparoscopic cholecystectomy. J Anesth 13:140–143CrossRefPubMed Fujii Y, Tanaka H, Toyooka H (1999) Prophylactic antiemetic therapy with droperidol in patients undergoing laparoscopic cholecystectomy. J Anesth 13:140–143CrossRefPubMed
13.
Zurück zum Zitat Leksowski K, Peryga P, Szyca R (2006) Ondansetron, metoclopramid, dexamethasone, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized study. Surg Endosc 20:878–882CrossRefPubMed Leksowski K, Peryga P, Szyca R (2006) Ondansetron, metoclopramid, dexamethasone, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized study. Surg Endosc 20:878–882CrossRefPubMed
14.
Zurück zum Zitat Morgan GE, Mikhail MS, Murray MJ (2002) Adjuncts to anesthesia. In: Morgan GE, Mikhail MS, Murray MJ (eds) Clinical anesthesiology. McGraw-Hill, New York, pp 242–252 Morgan GE, Mikhail MS, Murray MJ (2002) Adjuncts to anesthesia. In: Morgan GE, Mikhail MS, Murray MJ (eds) Clinical anesthesiology. McGraw-Hill, New York, pp 242–252
15.
Zurück zum Zitat Hesketh PJ, Gandara DR (1991) Serotonin antagonists: a new class of antiemetic agents. J Natl Cancer Inst 83:613–620CrossRefPubMed Hesketh PJ, Gandara DR (1991) Serotonin antagonists: a new class of antiemetic agents. J Natl Cancer Inst 83:613–620CrossRefPubMed
16.
Zurück zum Zitat Tramer MR, Moore RA, Reynolds DJ, McQuay HJ (1997) A quantitative systematic review of ondansetron in the treatment established postoperative nausea and vomiting. Anesthesiology 314:1088–1089 Tramer MR, Moore RA, Reynolds DJ, McQuay HJ (1997) A quantitative systematic review of ondansetron in the treatment established postoperative nausea and vomiting. Anesthesiology 314:1088–1089
17.
Zurück zum Zitat Helmy SA (1999) Prophylactic antiemetic efficacy of ondansetron in laparoscopic cholecystectomy under total intravenous anaesthesia: a randomised, double-blind comparison with droperidol, metoclopramide and placebo. Anaesthesia 54:266–270CrossRefPubMed Helmy SA (1999) Prophylactic antiemetic efficacy of ondansetron in laparoscopic cholecystectomy under total intravenous anaesthesia: a randomised, double-blind comparison with droperidol, metoclopramide and placebo. Anaesthesia 54:266–270CrossRefPubMed
18.
Zurück zum Zitat Naguib M, el Bakry AK, Khoshim MH, Channa AB, el Gammal M, el Gammal K, Elhattab YS, Attia M, Saddique A (1996) Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron, and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo. Can J Anaesth 43:226–231CrossRefPubMed Naguib M, el Bakry AK, Khoshim MH, Channa AB, el Gammal M, el Gammal K, Elhattab YS, Attia M, Saddique A (1996) Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron, and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo. Can J Anaesth 43:226–231CrossRefPubMed
19.
Zurück zum Zitat Shi Y, He X, Yang S, Ai B, Zhang C, Huang D, Dong M, Liu P, Zhou S, Han X (2007) Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: a prospective randomized controlled study. Chemotherapy 53:44–50CrossRefPubMed Shi Y, He X, Yang S, Ai B, Zhang C, Huang D, Dong M, Liu P, Zhou S, Han X (2007) Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: a prospective randomized controlled study. Chemotherapy 53:44–50CrossRefPubMed
20.
Zurück zum Zitat Kang YK, Park YH, Ryoo BY, Bang YJ, Cho KS, Shin DB, Kim HC, Lee KH, Park YS, Lee KS, Heo DS, Kim SY, Cho EK, Lim HY, Kim WK, Lee JA, Kim TY, Lee JC, Yoon HJ, Kim NK (2002) Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron. J Int Med Res 30:220–229PubMed Kang YK, Park YH, Ryoo BY, Bang YJ, Cho KS, Shin DB, Kim HC, Lee KH, Park YS, Lee KS, Heo DS, Kim SY, Cho EK, Lim HY, Kim WK, Lee JA, Kim TY, Lee JC, Yoon HJ, Kim NK (2002) Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron. J Int Med Res 30:220–229PubMed
21.
Zurück zum Zitat Fujii Y, Tanaka H (2002) Comparison of granisetron and ramosetron for the prevention of nausea and vomiting after thyroidectomy. Clin Ther 24:766–772CrossRefPubMed Fujii Y, Tanaka H (2002) Comparison of granisetron and ramosetron for the prevention of nausea and vomiting after thyroidectomy. Clin Ther 24:766–772CrossRefPubMed
22.
Zurück zum Zitat Fujii Y, Tanaka H (2002) Double-blind, placebo-controlled, dose-ranging study of ramosetron for the prevention of nausea and vomiting after thyroidectomy. Clin Ther 24:1148–1153CrossRefPubMed Fujii Y, Tanaka H (2002) Double-blind, placebo-controlled, dose-ranging study of ramosetron for the prevention of nausea and vomiting after thyroidectomy. Clin Ther 24:1148–1153CrossRefPubMed
23.
Zurück zum Zitat Fujii Y, Uemura A, Tanaka H (2002) Prophylaxis of nausea and vomiting after laparoscopic cholecystectomy with ramosetron: randomised controlled trial. Eur J Surg 168:583–586CrossRefPubMed Fujii Y, Uemura A, Tanaka H (2002) Prophylaxis of nausea and vomiting after laparoscopic cholecystectomy with ramosetron: randomised controlled trial. Eur J Surg 168:583–586CrossRefPubMed
24.
Zurück zum Zitat Quaynor H, Raeder JC (2002) Incidence and severity of postoperative nausea and vomiting are similar after metoclopramide 20 mg and ondansetron 8 mg given by the end of laparoscopic cholecystectomies. Acta Anaesthesiol Scand 46:109–113CrossRefPubMed Quaynor H, Raeder JC (2002) Incidence and severity of postoperative nausea and vomiting are similar after metoclopramide 20 mg and ondansetron 8 mg given by the end of laparoscopic cholecystectomies. Acta Anaesthesiol Scand 46:109–113CrossRefPubMed
25.
Zurück zum Zitat Grond S, Lynch J, Diefenbach C, Altrock K, Lehmann KA (1995) Comparison of ondansetron and droperidol in the prevention of nausea and vomiting after inpatient minor gynecologic surgery. Anesth Analg 81:603–607CrossRefPubMed Grond S, Lynch J, Diefenbach C, Altrock K, Lehmann KA (1995) Comparison of ondansetron and droperidol in the prevention of nausea and vomiting after inpatient minor gynecologic surgery. Anesth Analg 81:603–607CrossRefPubMed
26.
Zurück zum Zitat Honkavaara P (1996) Effect of ondansetron on nausea and vomiting after middle ear surgery during general anaesthesia. Br J Anaesth 76:316–318PubMed Honkavaara P (1996) Effect of ondansetron on nausea and vomiting after middle ear surgery during general anaesthesia. Br J Anaesth 76:316–318PubMed
27.
Zurück zum Zitat Paventi S, Santevecchi A, Ranieri R (2001) Efficacy of a single-dose ondansetron for preventing postoperative nausea and vomiting after laparoscopic cholecystectomy with sevoflurane and remifentanil infusion anaesthesia. Eur Rev Med Pharmacol Sci 5:59–63PubMed Paventi S, Santevecchi A, Ranieri R (2001) Efficacy of a single-dose ondansetron for preventing postoperative nausea and vomiting after laparoscopic cholecystectomy with sevoflurane and remifentanil infusion anaesthesia. Eur Rev Med Pharmacol Sci 5:59–63PubMed
28.
Zurück zum Zitat Fujii Y, Tanaka H, Somekawa Y (2004) A randomized, double-blind, placebo-controlled trial of ramosetron for preventing nausea and vomiting during termination of pregnancy. Int J Obstet Anesth 13:15–18CrossRefPubMed Fujii Y, Tanaka H, Somekawa Y (2004) A randomized, double-blind, placebo-controlled trial of ramosetron for preventing nausea and vomiting during termination of pregnancy. Int J Obstet Anesth 13:15–18CrossRefPubMed
29.
Zurück zum Zitat Fujii Y, Saitoh Y, Tanaka H, Toyooka H (2000) Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery. Anesth Analg 90:472–475CrossRefPubMed Fujii Y, Saitoh Y, Tanaka H, Toyooka H (2000) Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery. Anesth Analg 90:472–475CrossRefPubMed
30.
Zurück zum Zitat Gepstein R, Arinzon Z, Folman Y, Shuval I, Shabat S (2007) Efficacy and complications of patient-controlled analgesia treatment after spinal surgery. Surg Neurol 67:360–366CrossRefPubMed Gepstein R, Arinzon Z, Folman Y, Shuval I, Shabat S (2007) Efficacy and complications of patient-controlled analgesia treatment after spinal surgery. Surg Neurol 67:360–366CrossRefPubMed
31.
Zurück zum Zitat Papadimitriou L, Livanios S, Katsaros G, Hassiakos D, Koussi T, Demesticha T (2001) Prevention of postoperative nausea and vomiting after laparoscopic gynaecological surgery: combined antiemetic treatment with tropisetron and metoclopramide vs metoclopramide alone. Eur J Anaesthesiol 18:615–619PubMed Papadimitriou L, Livanios S, Katsaros G, Hassiakos D, Koussi T, Demesticha T (2001) Prevention of postoperative nausea and vomiting after laparoscopic gynaecological surgery: combined antiemetic treatment with tropisetron and metoclopramide vs metoclopramide alone. Eur J Anaesthesiol 18:615–619PubMed
32.
Zurück zum Zitat Sanchez-Ledesma MJ, Lopez-Olaondo L, Pueyo FJ, Carrascosa F, Ortega A (2002) A comparison of three antiemetic combinations for the prevention of postoperative nausea and vomiting. Anesth Analg 95:1590–1595CrossRefPubMed Sanchez-Ledesma MJ, Lopez-Olaondo L, Pueyo FJ, Carrascosa F, Ortega A (2002) A comparison of three antiemetic combinations for the prevention of postoperative nausea and vomiting. Anesth Analg 95:1590–1595CrossRefPubMed
33.
Zurück zum Zitat Biswas BN, Rudra A (2003) Comparison of granisetron and granisetron plus dexamethasone for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Acta Anaesthesiol Scand 47:79–83CrossRefPubMed Biswas BN, Rudra A (2003) Comparison of granisetron and granisetron plus dexamethasone for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Acta Anaesthesiol Scand 47:79–83CrossRefPubMed
34.
Zurück zum Zitat Coloma M, White PF, Markowitz SD, Whitten CW, Macaluso AR, Berrisford SB, Thornton KC (2002) Dexamethasone in combination with dolasetron for prophylaxis in the ambulatory setting: effect on outcome after laparoscopic cholecystectomy. Anesthesiology 96:1346–5130CrossRefPubMed Coloma M, White PF, Markowitz SD, Whitten CW, Macaluso AR, Berrisford SB, Thornton KC (2002) Dexamethasone in combination with dolasetron for prophylaxis in the ambulatory setting: effect on outcome after laparoscopic cholecystectomy. Anesthesiology 96:1346–5130CrossRefPubMed
35.
Zurück zum Zitat Caldwell CB, Ricotta JJ (1987) Changes in visceral blood flow with elevated intraabdominal pressure. J Surg Res 43:14–20CrossRefPubMed Caldwell CB, Ricotta JJ (1987) Changes in visceral blood flow with elevated intraabdominal pressure. J Surg Res 43:14–20CrossRefPubMed
36.
Zurück zum Zitat Diebel LN, Dulchavsky SA, Wilson RF (1992) Effect of increased intraabdominal pressure on mesenteric arterial and intestinal mucosal blood flow. J Trauma 33:45–48PubMedCrossRef Diebel LN, Dulchavsky SA, Wilson RF (1992) Effect of increased intraabdominal pressure on mesenteric arterial and intestinal mucosal blood flow. J Trauma 33:45–48PubMedCrossRef
37.
Zurück zum Zitat Goll V, Akça O, Greif R, Freitag H, Arkiliç CF, Scheck T, Zoeggeler A, Kurz A, Krieger G, Lenhardt R, Sessler DI (2001) Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting. Anesth Analg 92:112–117CrossRefPubMed Goll V, Akça O, Greif R, Freitag H, Arkiliç CF, Scheck T, Zoeggeler A, Kurz A, Krieger G, Lenhardt R, Sessler DI (2001) Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting. Anesth Analg 92:112–117CrossRefPubMed
38.
Zurück zum Zitat Fujii Y, Saitoh Y, Tanaka H, Toyooka H (1999) Ramosetron vs granisetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Can J Anaesth 46:991–993CrossRefPubMed Fujii Y, Saitoh Y, Tanaka H, Toyooka H (1999) Ramosetron vs granisetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Can J Anaesth 46:991–993CrossRefPubMed
39.
Zurück zum Zitat Choi YS, Shim JK, Yoon do H, Jeon DH, Lee JY, Kwak YL (2008) Effect of ramosetron on patient-controlled analgesia-related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron. Spine 33:E602–E606CrossRefPubMed Choi YS, Shim JK, Yoon do H, Jeon DH, Lee JY, Kwak YL (2008) Effect of ramosetron on patient-controlled analgesia-related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron. Spine 33:E602–E606CrossRefPubMed
40.
Zurück zum Zitat Hartung J (1996) Twenty-four of twenty-seven studies show a greater incidence of emesis with nitrous oxide than with alternative anesthetics. Anesth Analg 83:114–116CrossRefPubMed Hartung J (1996) Twenty-four of twenty-seven studies show a greater incidence of emesis with nitrous oxide than with alternative anesthetics. Anesth Analg 83:114–116CrossRefPubMed
41.
Zurück zum Zitat Tramer M, Moore A, McQuay H (1996) Omitting nitrous oxide in general anesthesia: meta-analysis of intraoperative, awareness, and postoperative emesis in randomized controlled trials. Br J Anaesth 76:186–193PubMed Tramer M, Moore A, McQuay H (1996) Omitting nitrous oxide in general anesthesia: meta-analysis of intraoperative, awareness, and postoperative emesis in randomized controlled trials. Br J Anaesth 76:186–193PubMed
43.
Zurück zum Zitat Glass PS, Gan TJ, Howell S (1999) A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg 89:S7–S14CrossRefPubMed Glass PS, Gan TJ, Howell S (1999) A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg 89:S7–S14CrossRefPubMed
44.
Zurück zum Zitat Kapila A, Glass PS, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL (1995) Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 83:968–975CrossRefPubMed Kapila A, Glass PS, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL (1995) Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 83:968–975CrossRefPubMed
45.
Zurück zum Zitat Song D, White PF (1999) Remifentanil as an adjuvant during desflurane anesthesia facilitates early recovery after ambulatory surgery. J Clin Anesth 11:364–367CrossRefPubMed Song D, White PF (1999) Remifentanil as an adjuvant during desflurane anesthesia facilitates early recovery after ambulatory surgery. J Clin Anesth 11:364–367CrossRefPubMed
Metadaten
Titel
Ramosetron versus ondansetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy
verfasst von
Junghee Ryu
Yun-Mi So
Jungwon Hwang
Sang-Hwan Do
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 4/2010
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-009-0670-5

Weitere Artikel der Ausgabe 4/2010

Surgical Endoscopy 4/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.